Is This the End for Compounded Tirzepatide? Judge Says NO to Injunction

Compounded Tirzepatide Legal Battle: What You Need to Know

In this episode of The Downsized, hosts Christopher Durham discusses the intensifying legal battle over compounded tirzepatide between the Outsourcing Facilities Association (OFA) and the U.S. Food and Drug Administration (FDA). A recent court decision by Judge Mark Pittman denied the OFA's motion for a preliminary injunction, which means the FDA's stance that the tirzepatide shortage has been resolved stands. The episode explains what this implies for patients depending on compounded GLP-1 medications. The discussion includes what the decision means for 503A and 503B pharmacies, highlighting their role in providing personalized medications, and explores the potential need for patients Zepbound or Mounjaro. They emphasize staying informed, communicating with healthcare providers, and advocating for oneself. Additionally, Christopher and Laraine touch on another ongoing lawsuit concerning compounded semaglutide and notable industry responses from pharmaceutical companies like Eli Lilly and Novo Nordisk. Tune in for updates and guidance on navigating these legal challenges and ensuring your health needs are met.

BOOK THE DOWNSIZED AT SEA CRUISE: https://thedownsized.org/downsized-at-sea-2025/

DOWNSIZED WEBSITE: https://thedownsized.org/

JOIN CLUB DOWNSIZED: https://www.youtube.com/@thedownsized/join

DOWNSIZED GLP-1 COMPANION PRODUCT STORE: https://thedownsized.org/downsized-store

We use Mochi Health: https://joinmochi.com/. Use Laraine’s code for $40 off: QIYGO8.

00:00 Introduction to the Legal Battle Over Compounded Tirzepatide
00:13 Welcome to The Downsized
00:41 Overview of the OFA vs. FDA Lawsuit
01:27 Implications for 503A and 503B Pharmacies
02:01 What This Means for Patients
03:13 Next Steps in the Legal Battle
03:47 How to Stay Informed and Advocate for Yourself
04:19 Planning Ahead for Your Health
04:42 New Developments and Future Outlook
05:17 Commitment to Advocacy and Conclusion

Видео Is This the End for Compounded Tirzepatide? Judge Says NO to Injunction канала DOWNSIZED